Prognosis
U.K. Poised to Clear Astra Shot as Need for Vaccines Grows
- Expanding immunizations could let Britain ease lockdowns
- Spread of new virus variant threatens to force school closings
This article is for subscribers only.
The U.K. is poised to approve the Covid-19 vaccine produced by AstraZeneca Plc and the University of Oxford, giving the country another powerful tool to fight the pandemic as concern mounts over rising infections.
Britain’s drug regulator could clear the shot for use as early as this week, according to a person familiar with the matter, who asked not to be identified because the deliberations are confidential. AstraZeneca Chief Executive Officer Pascal Soriot and U.K. health officials had previously said they hoped for approval by the end of the year.